68 related articles for article (PubMed ID: 26260846)
1. Lipophagy mediated carbohydrate-induced changes of lipid metabolism via oxidative stress, endoplasmic reticulum (ER) stress and ChREBP/PPARγ pathways.
Zhao T; Wu K; Hogstrand C; Xu YH; Chen GH; Wei CC; Luo Z
Cell Mol Life Sci; 2020 May; 77(10):1987-2003. PubMed ID: 31392349
[TBL] [Abstract][Full Text] [Related]
2. SIRT7 regulates lipogenesis in adipocytes through deacetylation of PPARγ2.
Akter F; Tsuyama T; Yoshizawa T; Sobuz SU; Yamagata K
J Diabetes Investig; 2021 Oct; 12(10):1765-1774. PubMed ID: 33955199
[TBL] [Abstract][Full Text] [Related]
3. Role of hepatic peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease.
Lee SM; Muratalla J; Sierra-Cruz M; Cordoba-Chacon J
J Endocrinol; 2023 Apr; 257(1):. PubMed ID: 36688873
[TBL] [Abstract][Full Text] [Related]
4. Oxysterol-binding protein-like 3 is a novel target gene of peroxisome proliferator-activated receptor γ in fatty liver disease.
Aibara D; Sakaguchi A; Matsusue K
Mol Cell Endocrinol; 2023 Apr; 565():111887. PubMed ID: 36781118
[TBL] [Abstract][Full Text] [Related]
5. Does Pro(12)Ala Polymorphism Enhance the Physiological Role of PPARγ2?
Pereira AC; Oliveira R; Castro AC; Fernandes R
PPAR Res; 2013; 2013():401274. PubMed ID: 23983677
[TBL] [Abstract][Full Text] [Related]
6. Limonoids isolated from Chisocheton ceramicus Miq. and the antiadipogenic mechanism of action of ceramicine B.
Bailly C
Arch Pharm (Weinheim); 2024 Apr; ():e2400160. PubMed ID: 38678480
[TBL] [Abstract][Full Text] [Related]
7. 14-3-3 Proteins Are on the Crossroads of Cancer, Aging, and Age-Related Neurodegenerative Disease.
Fan X; Cui L; Zeng Y; Song W; Gaur U; Yang M
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31323761
[TBL] [Abstract][Full Text] [Related]
8. Degradation of selenoprotein S and selenoprotein K through PPARγ-mediated ubiquitination is required for adipocyte differentiation.
Lee JH; Jang JK; Ko KY; Jin Y; Ham M; Kang H; Kim IY
Cell Death Differ; 2019 Jun; 26(6):1007-1023. PubMed ID: 30082770
[TBL] [Abstract][Full Text] [Related]
9. Differential expression and accumulation of 14-3-3 paralogs in 3T3-L1 preadipocytes and differentiated cells.
Gojanovich AD; Bustos DM; Uhart M
Biochem Biophys Rep; 2016 Sep; 7():106-112. PubMed ID: 28955896
[TBL] [Abstract][Full Text] [Related]
10. Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer.
Athreya AP; Kalari KR; Cairns J; Gaglio AJ; Wills QF; Niu N; Weinshilboum R; Iyer RK; Wang L
Oncotarget; 2017 Apr; 8(16):27199-27215. PubMed ID: 28423712
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
12. Aronia melanocarpa Extract Ameliorates Hepatic Lipid Metabolism through PPARγ2 Downregulation.
Park CH; Kim JH; Lee EB; Hur W; Kwon OJ; Park HJ; Yoon SK
PLoS One; 2017; 12(1):e0169685. PubMed ID: 28081181
[TBL] [Abstract][Full Text] [Related]
13. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
Geisler CE; Renquist BJ
J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
[TBL] [Abstract][Full Text] [Related]
14. Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation.
Silva AKS; Peixoto CA
Cell Mol Life Sci; 2018 Aug; 75(16):2951-2961. PubMed ID: 29789866
[TBL] [Abstract][Full Text] [Related]
15. 14-3-3β and γ differentially regulate peroxisome proliferator activated receptor γ2 transactivation and hepatic lipid metabolism.
Park S; Yoo S; Kim J; An HT; Kang M; Ko J
Biochim Biophys Acta; 2015 Oct; 1849(10):1237-47. PubMed ID: 26260846
[TBL] [Abstract][Full Text] [Related]
16. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.
Schadinger SE; Bucher NL; Schreiber BM; Farmer SR
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1195-205. PubMed ID: 15644454
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]